Immunome Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Immunome stock has a consensus rating of "Strong Buy" and an average price target of $35.2. The average 1-year stock price forecast is 82.29% higher than the current stock price, while the lowest is $24 (+24.29%) and the highest is $40 (+107.15%).

Price Target: $35.2 (+82.29%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$24	$35.2	$36	$40
Change	+24.29%	+82.29%	+86.43%	+107.15%

Analyst Ratings

The average analyst rating for Immunome stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	12	11	11	11	12	12
Buy	3	3	3	3	3	3
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	14	14	14	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dara Azar Stifel Nicolaus	Stifel Nicolaus	Hold Maintains $24	Hold	Maintains	$24	+24.29%	Oct 6, 2026
Charles Zhu LifeSci Capital	LifeSci Capital	Buy Maintains $40	Buy	Maintains	$40	+107.15%	Oct 5, 2026
Lukas Shumway Barclays	Barclays	Buy Maintains $36	Buy	Maintains	$36	+86.43%	Oct 1, 2026
Matthew Venezia Alliance Global Partners	Alliance Global Partners	Buy Initiates $32	Buy	Initiates	$32	+65.72%	Sep 21, 2026
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $40	Buy	Reiterates	$40	+107.15%	Sep 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

285.71K

from 6.94M

-95.88%

from 6.94M

Revenue Next Year

53.85M

from 285.71K

18,747.97%

from 285.71K

EPS This Year

-2.29

from -2.43

EPS Next Year

-2.43

from -2.29

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	14.02M	9.04M	6.94M	285.71K
Revenue Growth	-	-	-	-35.50%	-23.23%	-95.88%
Operating Income	-25.20M	-36.90M	-28.73M	-153.46M	-214.11M	-301.40M
Net Income	-24.71M	-36.90M	-106.81M	-292.96M	-212.39M	-273.50M
EPS	-	-	-	-	-2.43	-2.29
Free Cash Flow	-	-	-	-	-200.60M	-344.23M
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	4.0M
Avg	285,710
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-42.4%
Avg	-95.9%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-2.02
Avg	-2.29
Low	-2.56

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-